Loading…
FutureChem has signed a contract with Eli Lilly subsidiary Avid to manufacture and supply radiopharmaceuticals for Alzheimer's diagnostic clinical trials in South Korea, valued at $1.259 million.
CMIT has signed a six-year contract with Eli Lilly/AVID to produce F-18 labeled AV-1451 PET radiopharmaceutical for early detection of Alzheimer's disease at its Southern Isotopes facility in Shreveport.